Cancer Immunology & Immunotherapy
Immunotherapy is that the "treatment of illness by causing, enhancing, or suppressing an immune response". Immunotherapies designed to elicit or amplify an immunologic response are classified as activation immunotherapies, whereas immunotherapies that cut back or suppress art classified as suppression immunotherapies. Immunomodulatory regimens usually have fewer aspect effects than existing medication, together with less potential for making resistance once treating microbic illness. Cell-based immunotherapies are effective for a few cancers. Immune effector cells like lymphocytes, macrophages, nerve fibre cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work along to defend the body against cancer by targeting abnormal antigens expressed on the surface of neoplasm cells.
Cancer medical specialty is a knowledge base branch of biology that's involved with understanding the role of the system within the progression and development of cancer; the foremost well-known application is cancer therapy that utilises the system as a treatment for cancer. Cancer immunosurveillance and immunoediting are supported protection against development of tumors in animal systems and identification of targets for immune recognition of human cancer. Cancer medical specialty is a knowledge base branch of biology involved with the role of the system within the progression and development of cancer the foremost well-known application is cancer therapy, wherever the system is employed to treat cancer.
- Immunomodulators
- Activation Immunotherapies
- Vaccination
- Helminthic Therapies
- Immunosuppressive Drugs
- Immune Recovery
- T-cell Adoptive Transfer
Related Conference of Cancer Immunology & Immunotherapy
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Cancer Immunology & Immunotherapy Conference Speakers
Recommended Sessions
- Allergic Reactions and Hypersensitivity
- Antigen and Antibody Interactions
- Auto Immune Diseases
- Bioinformatics
- Cancer Immunology & Immunotherapy
- Cell Biology
- Classical Immunology
- Clinical Immunology
- Cloning Vectors
- Congenital and Acquired Immunodeficiency
- Developmental Immunology
- Diagnostic Immunology
- DNA Damage, Repair, Replication and Transcription
- Ecoimmunology & Behavioral Immunity
- Epidemiology
- Genetics
- Genomes
- HIV/AIDS
- Immune Disorders
- Immune Responses Against Tumors and Transplants
- Immunological Tolerance
- Infectious Diseases
- Microbial, Parasitic & Fungal Immunology
- Molecular & Cellular Biochemistry
- Parasitology
- Veterinary Immunology
- Virology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance - Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Autoimmune & Inflammatory Disorders - Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Cancer Immunology & Tumor Microenvironment - Immunology 2026 (France)
- Cellular Signaling & Cell Fate Determination - Immunology 2026 (France)
- Clinical and Translational Immunology - Immunology 2026 (France)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunogenetics & Epigenetic Regulation - Immunology 2026 (France)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunometabolism - Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Immunotherapy & Immune Modulation - Immunology 2026 (France)
- Infectious Diseases - Antibiotics 2026 (UK)
- Infectious Diseases & Host–Pathogen Interactions - Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate and Adaptive Immune Mechanisms - Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Innovations in Cell Biology & Imaging Technologies - Immunology 2026 (France)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Molecular & Cellular Immunology - Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Neuroimmunology & Brain–Immune Interactions - Immunology 2026 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Stem Cells & Regenerative Immunology - Immunology 2026 (France)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Vaccines & Vaccine Technology - Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)

